GM-CSF but not IL-17 is critical for the development of severe interstitial lung disease in SKG mice

Journal of Immunology

Volumn 193, Issue 2, 2014, Pages 849-859

  Shiomi, Aoi ^a   Usui, Takashi ^a   Ishikawa, Yuki ^a   Shimizu, Masakazu ^a   Murakami, Kosaku ^a   Mimori, Tsuneyo ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1; INTERLEUKIN 17; INTERLEUKIN 6; ZYMOSAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHRITIS; ARTICLE; CD4+ T LYMPHOCYTE; CLINICAL ASSESSMENT; CLINICAL FEATURE; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; INTERSTITIAL LUNG DISEASE; LUNG FIBROSIS; MACROPHAGE; MORTALITY; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; TH17 CELL; VIRUS NEUTRALIZATION;

ANIMALS; ANTIBODIES, NEUTRALIZING; ARTHRITIS; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CONNECTIVE TISSUE DISEASES; DISEASE MODELS, ANIMAL; FEMALE; FLOW CYTOMETRY; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; INTERLEUKIN-17; INTERLEUKIN-1BETA; INTERLEUKIN-6; LUNG; LUNG DISEASES, INTERSTITIAL; MACROPHAGES; MICE; MICE, INBRED BALB C; NEUTROPHILS; SEVERITY OF ILLNESS INDEX; TH17 CELLS; TIME FACTORS; ZYMOSAN;

EID: 84904266329     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1303255     Document Type: Article

References (54)

1. Castelino, F. V., and J. Varga. 2010. Interstitial lung disease in connective tissue diseases: evolving concepts of pathogenesis and management. Arthritis Res. Ther. 12: 213.
2. Katzenstein, A. L., and J. L. Myers. 1998. Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. Am. J. Respir. Crit. Care Med. 157: 1301-1315.
3. Parra, E. R., G. S. Noleto, L. J. Tinoco, and V. L. Capelozzi. 2008. Immunophenotyping and remodeling process in small airways of idiopathic interstitial pneumonias: functional and prognostic significance. Clin. Respir. J. 2: 227-238.
4. Wallaert, B. 1990. Subclinical alveolitis in immunologic systemic disorders. Lung 168: 974-983.
5. Manganelli, P., F. Salaffi, and A. Pesci. 1997. Clinical and subclinical alveolitis in connective tissue diseases assessed by bronchoalveolar lavage. Semin. Arthritis Rheum. 26: 740-754.
6. Garcia, J. G., N. Parhami, D. Killam, P. L. Garcia, and B. A. Keogh. 1986. Bronchoalveolar lavage fluid evaluation in rheumatoid arthritis. Am. Rev. Respir. Dis. 133: 450-454.
7. Garcia, J. G., H. L. James, S. Zinkgraf, M. B. Perlman, and B. A. Keogh. 1987. Lower respiratory tract abnormalities in rheumatoid interstitial lung disease: potential role of neutrophils in lung injury. Am. Rev. Respir. Dis. 136: 811-817.
8. Marie, I., E. Hachulla, P. Chérin, S. Dominique, P. Y. Hatron, M. F. Hellot, B. Devulder, S. Herson, H. Levesque, and H. Courtois. 2002. Interstitial lung disease in polymyositis and dermatomyositis. Arthritis Rheum. 47: 614-622.
9. Turesson, C., E. L. Matteson, T. V. Colby, Z. Vuk-Pavlovic, R. Vassallo, C. M. Weyand, H. D. Tazelaar, and A. H. Limper. 2005. Increased CD4+ T cell infiltrates in rheumatoid arthritis-associated interstitial pneumonitis compared with idiopathic interstitial pneumonitis. Arthritis Rheum. 52: 73-79.
10. Moore, B., W. E. Lawson, T. D. Oury, T. H. Sisson, K. Raghavendran, and C. M. Hogaboam. 2013. Animal models of fibrotic lung disease. Am. J. Respir. Cell Mol. Biol. 49: 167-179.
11. Sakaguchi, N., T. Takahashi, H. Hata, T. Nomura, T. Tagami, S. Yamazaki, T. Sakihama, T. Matsutani, I. Negishi, S. Nakatsuru, and S. Sakaguchi. 2003. Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice. Nature 426: 454-460.
12. Keith, R. C., J. L. Powers, E. F. Redente, A. Sergew, R. J. Martin, A. Gizinski, V. M. Holers, S. Sakaguchi, and D. W. Riches. 2012. A novel model of rheumatoid arthritis-associated interstitial lung disease in SKG mice. Exp. Lung Res. 38: 55-66.
13. Hirota, K., M. Hashimoto, H. Yoshitomi, S. Tanaka, T. Nomura, T. Yamaguchi, Y. Iwakura, N. Sakaguchi, and S. Sakaguchi. 2007. T cell self-reactivity forms a cytokine milieu for spontaneous development of IL-17+ Th cells that cause autoimmune arthritis. J. Exp. Med. 204: 41-47.
14. Yoshitomi, H., N. Sakaguchi, K. Kobayashi, G. D. Brown, T. Tagami, T. Sakihama, K. Hirota, S. Tanaka, T. Nomura, I. Miki, et al. 2005. A role for fungal beta-glucans and their receptor Dectin-1 in the induction of autoimmune arthritis in genetically susceptible mice. J. Exp. Med. 201: 949-960.
15. Hashimoto, M., K. Hirota, H. Yoshitomi, S. Maeda, S. Teradaira, S. Akizuki, P. Prieto-Martin, T. Nomura, N. Sakaguchi, J. Köhl, et al. 2010. Complement drives Th17 cell differentiation and triggers autoimmune arthritis. J. Exp. Med. 207: 1135-1143.
16. Zhang, Y., G. Ren, M. Guo, X. Ye, J. Zhao, L. Xu, J. Qi, F. Kan, M. Liu, and D. Li. 2013. Synergistic effects of interleukin-1β and interleukin-17A antibodies on collagen-induced arthritis mouse model. Int. Immunopharmacol. 15: 199-205.
17. van den Berg, W. B., and I. B. McInnes. 2013. Th17 cells and IL-17 a - focus on immunopathogenesis and immunotherapeutics. Semin. Arthritis Rheum. 43: 158-170.
18. Nakae, S., A. Nambu, K. Sudo, and Y. Iwakura. 2003. Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J. Immunol. 171: 6173-6177.
19. Codarri, L., G. Gyülvészi, V. Tosevski, L. Hesske, A. Fontana, L. Magnenat, T. Suter, and B. Becher. 2011. RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation. Nat. Immunol. 12: 560-567.
20. El-Behi, M., B. Ciric, H. Dai, Y. Yan, M. Cullimore, F. Safavi, G. X. Zhang, B. N. Dittel, and A. Rostami. 2011. The encephalitogenicity of T(H)17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF. Nat. Immunol. 12: 568-575.
21. Ye, P., W. Chen, J. Wu, X. Huang, J. Li, S. Wang, Z. Liu, G. Wang, X. Yang, P. Zhang, et al. 2013. GM-CSF contributes to aortic aneurysms resulting from SMAD3 deficiency. J. Clin. Invest. 123: 2317-2331.
22. Wakasa-Morimoto, C., T. Toyosaki-Maeda, T. Matsutani, R. Yoshida, S. Nakamura-Kikuoka, M. Maeda-Tanimura, H. Yoshitomi, K. Hirota, M. Hashimoto, H. Masaki, et al. 2008. Arthritis and pneumonitis produced by the same T cell clones from mice with spontaneous autoimmune arthritis. Int. Immunol. 20: 1331-1342.
23. Nishikomori, R., R. O. Ehrhardt, and W. Strober. 2000. T helper type 2 cell differentiation occurs in the presence of interleukin 12 receptor beta2 chain expression and signaling. J. Exp. Med. 191: 847-858.
24. Frankel, S. K., B. M. Moats-Staats, C. D. Cool, M. W. Wynes, A. D. Stiles, and D. W. Riches. 2005. Human insulin-like growth factor-IA expression in transgenic mice promotes adenomatous hyperplasia but not pulmonary fibrosis. Am. J. Physiol. Lung Cell. Mol. Physiol. 288: L805-L812.
25. Yoshida, H., M. Hashizume, M. Suzuki, and M. Mihara. 2011. Induction of high-dose tolerance to the rat anti-mouse IL-6 receptor antibody in NZB/NZW F1 mice. Rheumatol. Int. 31: 1445-1449.
26. Tansey, D., A. U. Wells, T. V. Colby, S. Ip, A. Nikolakoupolou, R. M. du Bois, D. M. Hansell, and A. G. Nicholson. 2004. Variations in histological patterns of interstitial pneumonia between connective tissue disorders and their relationship to prognosis. Histopathology 44: 585-596.
27. de Lauretis, A., S. Veeraraghavan, and E. Renzoni. 2011. Review series: aspects of interstitial lung disease: connective tissue disease-associated interstitial lung disease: how does it differ from IPF? How should the clinical approach differ? Chron. Respir. Dis. 8: 53-82.
28. Bondeson, J., K. A. Browne, F. M. Brennan, B. M. Foxwell, and M. Feldmann. 1999. Selective regulation of cytokine induction by adenoviral gene transfer of IkappaBalpha into human macrophages: lipopolysaccharide-induced, but not zymosan-induced, proinflammatory cytokines are inhibited, but IL-10 is nuclear factor-kappaB independent. J. Immunol. 162: 2939-2945.
29. Lukens, J. R., M. J. Barr, D. D. Chaplin, H. Chi, and T. D. Kanneganti. 2012. Inflammasome-derived IL-1β regulates the production of GM-CSF by CD4(+) T cells and γδ T cells. J. Immunol. 188: 3107-3115.
30. Atamas, S. P., V. V. Yurovsky, R. Wise, F. M. Wigley, C. J. Goter Robinson, P. Henry, W. J. Alms, and B. White. 1999. Production of type 2 cytokines by CD8+ lung cells is associated with greater decline in pulmonary function in patients with systemic sclerosis. Arthritis Rheum. 42: 1168-1178.
31. Luzina, I. G., S. P. Atamas, R. Wise, F. M. Wigley, J. Choi, H. Q. Xiao, and B. White. 2003. Occurrence of an activated, profibrotic pattern of gene expression in lung CD8+ T cells from scleroderma patients. Arthritis Rheum. 48: 2262-2274.
32. Luzina, I. G., N. W. Todd, A. T. Iacono, and S. P. Atamas. 2008. Roles of T lymphocytes in pulmonary fibrosis. J. Leukoc. Biol. 83: 237-244.
33. Lo Re, S., D. Lison, and F. Huaux. 2013. CD4+ T lymphocytes in lung fibrosis: diverse subsets, diverse functions. J. Leukoc. Biol. 93: 499-510.
34. Vij, R., and M. E. Strek. 2013. Diagnosis and treatment of connective tissue disease-associated interstitial lung disease. Chest 143: 814-824.
35. Shimizu, Y., H. Kuwabara, A. Ono, S. Higuchi, T. Hisada, K. Dobashi, M. Utsugi, Y. Mita, and M. Mori. 2006. Intracellular Th1/Th2 balance of pulmonary CD4(+) T cells in patients with active interstitial pneumonia evaluated by serum KL-6. Immunopharmacol. Immunotoxicol. 28: 295-304.
36. Kolarz, G., O. Scherak, W. Popp, L. Ritschka, N. Thumb, A. Wottawa, and H. Zwick. 1993. Bronchoalveolar lavage in rheumatoid arthritis. Br. J. Rheumatol. 32: 556-561.
37. Nagasawa, Y., T. Takada, T. Shimizu, J. Narita, H. Moriyama, M. Terada, E. Suzuki, and F. Gejyo. 2009. Inflammatory cells in lung disease associated with rheumatoid arthritis. Intern. Med. 48: 1209-1217.
38. Enomoto, K., T. Takada, E. Suzuki, T. Ishida, H. Moriyama, H. Ooi, T. Hasegawa, H. Tsukada, M. Nakano, and F. Gejyo. 2003. Bronchoalveolar lavage fluid cells in mixed connective tissue disease. Respirology 8: 149-156.
39. Sauty, A., T. Rochat, O. D. Schoch, J. Hamacher, A. M. Kurt, J. M. Dayer, and L. P. Nicod. 1997. Pulmonary fibrosis with predominant CD8 lymphocytic alveolitis and anti-Jo-1 antibodies. Eur. Respir. J. 10: 2907-2912.
40. Yamadori, I., J. Fujita, H. Kajitani, S. Bandoh, M. Tokuda, Y. Yang, Y. Ohtsuki, T. Yoshinouchi, T. Kamei, and T. Ishida. 2000. Lymphocyte subsets in lung tissues of non-specific interstitial pneumonia and pulmonary fibrosis associated with collagen vascular disorders: correlation with CD4/CD8 ratio in bronchoalveolar lavage. Lung 178: 361-370.
41. Parajuli, B., Y. Sonobe, J. Kawanokuchi, Y. Doi, M. Noda, H. Takeuchi, T. Mizuno, and A. Suzumura. 2012. GM-CSF increases LPS-induced production of proinflammatory mediators via upregulation of TLR4 and CD14 in murine microglia. J. Neuroinflammation 9: 268.
42. Sorgi, C. A., S. Rose, N. Court, D. Carlos, F. W. Paula-Silva, P. A. Assis, F. G. Frantz, B. Ryffel, V. Quesniaux, and L. H. Faccioli. 2012. GM-CSF priming drives bone marrow-derived macrophages to a pro-inflammatory pattern and downmodulates PGE2 in response to TLR2 ligands. PLoS One 7: e40523.
43. Berclaz, P. Y., B. Carey, M. D. Fillipi, K. Wernke-Dollries, N. Geraci, S. Cush, T. Richardson, J. Kitzmiller, M. O'Connor, C. Hermoyian, et al. 2007. GM-CSF regulates a PU.1-dependent transcriptional program determining the pulmonary response to LPS. Am. J. Respir. Cell Mol. Biol. 36: 114-121.
44. Sonderegger, I., G. Iezzi, R. Maier, N. Schmitz, M. Kurrer, and M. Kopf. 2008. GM-CSF mediates autoimmunity by enhancing IL-6-dependent Th17 cell development and survival. J. Exp. Med. 205: 2281-2294.
45. Khameneh, H. J., S. A. Isa, L. Min, F. W. Nih, and C. Ruedl. 2011. GM-CSF signalling boosts dramatically IL-1 production. PLoS One 6: e23025.
46. Shi, Y., C. H. Liu, A. I. Roberts, J. Das, G. Xu, G. Ren, Y. Zhang, L. Zhang, Z. R. Yuan, H. S. Tan, et al. 2006. Granulocyte-macrophage colony-stimulating factor (GM-CSF) and T-cell responses: what we do and don't know. Cell Res. 16: 126-133.
47. Johnson, G. R., T. J. Gonda, D. Metcalf, I. K. Hariharan, and S. Cory. 1989. A lethal myeloproliferative syndrome in mice transplanted with bone marrow cells infected with a retrovirus expressing granulocyte-macrophage colony stimulating factor. EMBO J. 8: 441-448.
48. Kolls, J. K., and A. Lindén. 2004. Interleukin-17 family members and inflammation. Immunity 21: 467-476.
49. Tang, H., S. Pang, M. Wang, X. Xiao, Y. Rong, H. Wang, and Y. Q. Zang. 2010. TLR4 activation is required for IL-17-induced multiple tissue inflammation and wasting in mice. J. Immunol. 185: 2563-2569.
50. Spurlock, N. K., and J. E. Prittie. 2011. A review of current indications, adverse effects, and administration recommendations for intravenous immunoglobulin. J. Vet. Emerg. Crit. Care 21: 471-483.
51. Greenhill, S. R., and D. N. Kotton. 2009. Pulmonary alveolar proteinosis: a bench-to-bedside story of granulocyte-macrophage colony-stimulating factor dysfunction. Chest 136: 571-577.
52. Dranoff, G., A. D. Crawford, M. Sadelain, B. Ream, A. Rashid, R. T. Bronson, G. R. Dickersin, C. J. Bachurski, E. L. Mark, J. A. Whitsett, et al. 1994. Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis. Science 264: 713-716.
53. Vlahos, R., S. Bozinovski, J. A. Hamilton, and G. P. Anderson. 2006. Therapeutic potential of treating chronic obstructive pulmonary disease (COPD) by neutralising granulocyte macrophage-colony stimulating factor (GM-CSF). Pharmacol. Ther. 112: 106-115.
54. Burmester, G. R., M. E. Weinblatt, I. B. McInnes, D. Porter, O. Barbarash, M. Vatutin, I. Szombati, E. Esfandiari, M. A. Sleeman, and C. D. Kane, et al. 2013. Efficacy and safety of mavrilimumab in subjects with rheumatoid arthritis. Ann. Rheum. Dis. 72: 1445-1452.